ונלפאקסין
הערות שוליים

1 2 3 4 5 6 7 8 9  "Venlafaxine Hydrochloride Monograph for Professionals". Drugs.com. AHFS. ארכיון מ-27 בנובמבר 2020. נבדק ב-24 בדצמבר 2018. {{cite web}}:  (עזרה)
↑  הערך ונלפאקסין (אפקסור, ויאפקס), באתר InfoMed
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 633
↑  "Antidepressants: Another weapon against chronic pain". Mayo Clinic. ארכיון מ-26 באוקטובר 2021. נבדק ב-25 בינואר 2020. {{cite web}}:  (עזרה)
↑  Center for Drug Evaluation and Research, Venlafaxine (marketed as Effexor) Information, FDA, 2022-02-24
↑  "The Top 300 of 2022". ClinCalc. ארכיון מ-30 באוגוסט 2024. נבדק ב-30 באוגוסט 2024. {{cite web}}:  (עזרה)
↑  "Venlafaxine Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. נבדק ב-30 באוגוסט 2024. {{cite web}}:  (עזרה)
↑  ונלפאקסין באתר משרד הבריאות
↑  ונלפאקסין באתר infomed
↑  Grothe DR, Scheckner B, Albano D (במאי 2004). "Treatment of pain syndromes with venlafaxine". Pharmacotherapy. 24 (5): 621–629. doi:10.1592/phco.24.6.621.34748. PMID 15162896. {{cite journal}}:  (עזרה)
↑  Singh D, Saadabadi A (2022). "Venlafaxine". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 30570984.
↑  The Opioid System as the Interface between the Brain's Cognitive and Motivational Systems. Academic Press. 2018. p. 73. ISBN 978-0-444-64168-7. ארכיון מ-27 באוגוסט 2021. נבדק ב-9 במאי 2020. {{cite book}}:  (עזרה)
↑  N. Biglia, Riccardo Torta, R. Roagna, F. Maggiorotto, F. Cacciari, R. Ponzone, F. Kubatzki, P. Sismondi, Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors, Maturitas 52, 2005-09-16, עמ' 78–85 doi: 10.1016/j.maturitas.2005.01.001
↑  Schober CE, Ansani NT (בנובמבר 2003). "Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. 37 (11): 1703–1707. doi:10.1345/aph.1C483. PMID 14565812. {{cite journal}}:  (עזרה)
↑  "Medications". Stanford University School of Medicine, Center for Narcolepsy. 7 בפברואר 2003. אורכב מ-המקור ב-21 באוגוסט 2007. נבדק ב-3 בספטמבר 2007. {{cite web}}:  (עזרה)
↑  Ghanizadeh A, Freeman RD, Berk M (במרץ 2013). "Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials". Reviews on Recent Clinical Trials. 8 (1): 2–8. doi:10.2174/1574887111308010002. PMID 23157376. {{cite journal}}:  (עזרה)
↑  Pae CU, Lim HK, Ajwani N, Lee C, Patkar AA (ביוני 2007). "Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder". Expert Review of Neurotherapeutics. 7 (6): 603–615. doi:10.1586/14737175.7.6.603. PMID 17563244. {{cite journal}}:  (עזרה)
↑  Phelps NJ, Cates ME (בינואר 2005). "The role of venlafaxine in the treatment of obsessive-compulsive disorder". The Annals of Pharmacotherapy. 39 (1): 136–140. doi:10.1345/aph.1E362. PMID 15585743. {{cite journal}}:  (עזרה)
↑  Thase M, Asami Y, Wajsbrot D, Dorries K, Boucher M, Pappadopulos E (בפברואר 2017). "A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. 33 (2): 317–326. doi:10.1080/03007995.2016.1255185. PMID 27794623. {{cite journal}}:  (עזרה)
↑  Courtney DB (באוגוסט 2004). "Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials". Canadian Journal of Psychiatry. 49 (8): 557–563. doi:10.1177/070674370404900807. PMID 15453105. {{cite journal}}:  (עזרה)
1 2 3  Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P (ביולי 2020). "Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis". The Lancet. Psychiatry. 7 (7): 581–601. doi:10.1016/S2215-0366(20)30137-1. PMC 7303954. PMID 32563306. {{cite journal}}:  (עזרה)
↑  Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N (במאי 2021). "New generation antidepressants for depression in children and adolescents: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2021 (5): CD013674. doi:10.1002/14651858.CD013674.pub2. PMC 8143444. PMID 34029378. {{cite journal}}:  (עזרה)
1 2  Solmi M, Fornaro M, Ostinelli EG, Zangani C, Croatto G, Monaco F, Krinitski D, Fusar-Poli P, Correll CU (ביוני 2020). "Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects". World Psychiatry. 19 (2): 214–232. doi:10.1002/wps.20765. PMC 7215080. PMID 32394557. {{cite journal}}:  (עזרה)
1 2  Boaden K, Tomlinson A, Cortese S, Cipriani A (2 בספטמבר 2020). "Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment". Frontiers in Psychiatry. 11: 717. doi:10.3389/fpsyt.2020.00717. PMC 7493620. PMID 32982805. {{cite journal}}:  (עזרה)
1 2  Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E (בנובמבר 2013). "The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders". The American Journal of Psychiatry. 170 (11): 1249–1262. doi:10.1176/appi.ajp.2013.13020185. PMC 4091043. PMID 24030475. {{cite journal}}:  (עזרה)
1 2  Martin A Katzman, Leslie Jacobs, Venlafaxine in the treatment of panic disorder, Neuropsychiatric Disease and Treatment 3, 2007-02, עמ' 59–67
↑  Christer Allgulander, David Hackett, Eliseo Salinas, Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder: Twenty-four-week placebo-controlled dose-ranging study, The British Journal of Psychiatry 179, 2001-07, עמ' 15–22 doi: 10.1192/bjp.179.1.15
↑  Michael R. Liebowitz, Alan J. Gelenberg, Dennis Munjack, Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder, Archives of General Psychiatry 62, 2005-02-01, עמ' 190–198 doi: 10.1001/archpsyc.62.2.190
↑  Eric Hollander, Jennifer Friedberg, Stacey Wasserman, Andrea Allen, Melissa Birnbaum, Lorrin M. Koran, Venlafaxine in treatment-resistant obsessive-compulsive disorder, The Journal of Clinical Psychiatry 64, 2003-05, עמ' 546–550 doi: 10.4088/jcp.v64n0508
↑  Janardhanan C. Narayanaswamy, Biju Viswanath, Anish V. Cherian, Suresh Bada Math, Y. C. Janardhan Reddy, Venlafaxine in Treatment Resistant Obsessive-Compulsive Disorder, The Journal of Neuropsychiatry and Clinical Neurosciences 26, 2014-07, עמ' E44–E45 doi: 10.1176/appi.neuropsych.13080186
↑  Umberto Albert, Eugenio Aguglia, Filippo Bogetto, Venlafaxine Versus Clomipramine in the Treatment of Obsessive-Compulsive Disorder: A Preliminary Single-Blind, 12-Week, Controlled Study, The Journal of Clinical Psychiatry 63, 2002-11-01, עמ' 22189
1 2  Jonathan Davidson, David Baldwin, Dan J. Stein, Enrique Kuper, Isma Benattia, Saeed Ahmed, Ron Pedersen, Jeff Musgnung, Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release: A 6-Month Randomized Controlled Trial, Archives of General Psychiatry 63, 2006-10-01, עמ' 1158–1165 doi: 10.1001/archpsyc.63.10.1158
↑  Request Rejected, www.health.mil
↑  Antidepressants: Another weapon against chronic pain, Mayo Clinic (באנגלית)
↑  Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review
↑  Natalie N. Maffeo, Cary M. Springer, Julia D. Albright, A retrospective study on the clinical use and owner perception of venlafaxine efficacy as part of a multimodal treatment for canine fear, anxiety, and aggression, Journal of Veterinary Behavior 64-65, 2023-06-01, עמ' 54–59 doi: 10.1016/j.jveb.2023.06.004
↑  "Venlafaxine Side Effects in Detail". ארכיון מ-3 באוקטובר 2020. נבדק ב-3 בינואר 2018. {{cite web}}:  (עזרה)
↑  Khurana RN, Baudendistel TE (בדצמבר 2003). "Hypertensive crisis associated with venlafaxine". The American Journal of Medicine. 115 (8): 676–677. doi:10.1016/S0002-9343(03)00472-8. PMID 14656626. {{cite journal}}:  (עזרה)
↑  Thase ME (באוקטובר 1998). "Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients". The Journal of Clinical Psychiatry. 59 (10): 502–508. doi:10.4088/JCP.v59n1002. PMID 9818630. {{cite journal}}:  (עזרה)
1 2 3  Pregnancy, breastfeeding and fertility while taking venlafaxine, nhs.uk, ‏2022-02-15 (באנגלית)
↑  Medicines Adverse Reactions Committee
↑  Venlafaxine induced akathisia: A case report
↑  Venlafaxine, Desvenlafaxine, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012
↑  Dharminder Singh, Abdolreza Saadabadi, Venlafaxine, Treasure Island (FL): StatPearls Publishing, 2024
↑  Kolecki P (ביולי–באוגוסט 1997). "Isolated venlafaxine-induced serotonin syndrome". The Journal of Emergency Medicine. 15 (4): 491–493. doi:10.1016/S0736-4679(97)00078-4. PMID 9279702. {{cite journal}}:  (עזרה)
↑  "Hallucinations as a side effect of venlafaxine treatment". Psychiatry On-line. ארכיון מ-21 במאי 2008. נבדק ב-17 ביוני 2008. {{cite web}}:  (עזרה)
↑  R. Boland ,Verduin ,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 626
↑  Michele Fornaro, Annalisa Anastasia, Alessandro Valchera, Alessandro Carano, Laura Orsolini, Federica Vellante, Gabriella Rapini, Luigi Olivieri, Serena Di Natale, Giampaolo Perna, Giovanni Martinotti, Massimo Di Giannantonio, Domenico De Berardis, The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?, Frontiers in Psychiatry 10, 2019-05-03 doi: 10.3389/fpsyt.2019.00294
↑  Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ (ביוני 2012). "Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 580–587. doi:10.1001/archgenpsychiatry.2011.2048. PMC 3367101. PMID 22309973. {{cite journal}}:  (עזרה)
↑  Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J (בדצמבר 2006). "Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort". Archives of General Psychiatry. 63 (12): 1358–1367. doi:10.1001/archpsyc.63.12.1358. PMID 17146010. {{cite journal}}:  (עזרה)
↑  Rubino A, Roskell N, Tennis P, Mines D, Weich S, Andrews E (בפברואר 2007). "Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study". BMJ. 334 (7587): 242. doi:10.1136/bmj.39041.445104.BE. PMC 1790752. PMID 17164297. {{cite journal}}:  (עזרה)
1 2  "Antidepressants for children and teenagers: what works for anxiety and depression?". NIHR Evidence (Plain English summary) (באנגלית). National Institute for Health and Care Research. 3 בנובמבר 2022. doi:10.3310/nihrevidence_53342. {{cite journal}}:  (עזרה)
↑  Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, Ostinelli EG, Zangani C, Fornaro M, Estradé A, Fusar-Poli P, Carvalho AF, Solmi M (ביוני 2021). "Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review". World Psychiatry. 20 (2): 244–275. doi:10.1002/wps.20881. PMC 8129843. PMID 34002501. {{cite journal}}:  (עזרה)
↑  Pae CU (בדצמבר 2011). "Desvenlafaxine in the treatment of major depressive disorder". Expert Opinion on Pharmacotherapy. 12 (18): 2923–2928. doi:10.1517/14656566.2011.636033. PMID 22098230. {{cite journal}}:  (עזרה)
↑  Shams ME, Arneth B, Hiemke C, Dragicevic A, Müller MJ, Kaiser R, Lackner K, Härtter S (באוקטובר 2006). "CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine". Journal of Clinical Pharmacy and Therapeutics. 31 (5): 493–502. doi:10.1111/j.1365-2710.2006.00763.x. PMID 16958828. {{cite journal}}:  (עזרה)
↑  Dean L (2015). "Venlafaxine Therapy and CYP2D6 Genotype".  In Pratt VM, McLeod HL, Rubinstein WS,  et al. (eds.). Medical Genetics Summaries. National Center for Biotechnology Information (NCBI). PMID 28520361. Bookshelf ID: NBK305561. ארכיון מ-26 באוקטובר 2020. נבדק ב-7 בפברואר 2020. {{cite book}}:  (עזרה)
↑  Parker G, Blennerhassett J (באפריל 1998). "Withdrawal reactions associated with venlafaxine". The Australian and New Zealand Journal of Psychiatry. 32 (2): 291–294. doi:10.3109/00048679809062742. PMID 9588310. {{cite journal}}:  (עזרה)
1 2  R. Boland ,Verduin ,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 634
↑  Iliou T, Casta P, Lequeux J, Pochard L, Frauger E, Spadari M, Micallef J (2019). "Venlafaxine Abuse in a Patient With a History of Methylphenidate Abuse: A Case Report". Journal of Clinical Psychopharmacology. 39 (2): 172–174. doi:10.1097/JCP.0000000000001011. PMID 30811375.
↑  Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web-based misusers′ experiences
↑  Giulia Francesconi, Laura Orsolini, Duccio Papanti, John M. Corkery, Fabrizio Schifano, Venlafaxine as the 'baby ecstasy'? Literature overview and analysis of web-based misusers' experiences, Human Psychopharmacology 30, 2015-07, עמ' 255–261 doi: 10.1002/hup.2476
↑  Natalie N. Maffeo, Cary M. Springer, Julia D. Albright, A retrospective study on the clinical use and owner perception of venlafaxine efficacy as part of a multimodal treatment for canine fear, anxiety, and aggression, Journal of Veterinary Behavior 64-65, 2023-06-01, עמ' 54–59 doi: 10.1016/j.jveb.2023.06.004
1 2  Venlafaxine (Effexor) - dogs, Lort Smith Animal Hospital (ב־Australian English)
↑  Delphine Metz, Tiphaine Medam, Sylvia Masson, Double-blind, placebo-controlled trial of venlafaxine to treat behavioural disorders in cats: a pilot study, Journal of Feline Medicine and Surgery 24, 2022-06, עמ' 539–549 doi: 10.1177/1098612X211036792
| --- | --- |
בקרת זהויות :  NLI: 987007532676205171  BnF: cb136028605 (data)  LCCN: sh98003963 
הדגמת גודל ונלפאקסין